Akebia extends separation dates for COO Dahan to June 28 and CLO Hadas to June 14

Akebia Therapeutics, Inc.

COO Michel Dahan's separation extended from March 22 to June 28, 2024.
SVP/Chief Legal Officer Nicole Hadas separation extended from March 29 to June 14, 2024.
Both amendments signed on February 8, 2024; earlier retention agreements dated May 5, 2022.
Separations may further extend to Sept 22, 2024 upon certain specified events.

item 5.02

Executive movements

Machine-extracted from this filing. Every card cites the SEC source. See all recent executive movements.

Departed

Nicole R. Hadas

Senior Vice President, Chief Legal Officer and Secretary

AKBA · Akebia Therapeutics, Inc.

Effective: 2024-06-14
Filed: February 13, 2024, 6:59 PM ET

On February 8, 2024, the Company and Ms. Hadas agreed to further extend the effective date of her separation to June 14, 2024

Departed

Michel Dahan

Chief Operating Officer

AKBA · Akebia Therapeutics, Inc.

Effective: 2024-06-28
Filed: February 13, 2024, 6:59 PM ET

On February 8, 2024, the Company and Mr. Dahan agreed to further extend the effective date of his separation to June 28, 2024

Key facts

Extracted from this filing and checked against the source text.

Executive change SEC 8-K Item 5.02 confidence 0.95

Nicole R. Hadas departed as Senior Vice President, Chief Legal Officer and Secretary at Akebia Therapeutics, Inc..

Action: separation extended
Role: Senior Vice President, Chief Legal Officer and Secretary

Exact text from the filing

On February 8, 2024, the Company and Ms. Hadas agreed to further extend the effective date of her separation to June 14, 2024

View on SEC.gov

Executive change SEC 8-K Item 5.02 confidence 0.95

Michel Dahan departed as Chief Operating Officer at Akebia Therapeutics, Inc..

Action: separation extended
Role: Chief Operating Officer

Exact text from the filing

On February 8, 2024, the Company and Mr. Dahan agreed to further extend the effective date of his separation to June 28, 2024

View on SEC.gov

Akebia Therapeutics, Inc. filing history →

Source: SEC EDGAR

accession 0001517022-24-000019

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.